Translational Award

The Translational Award is a grant scheme to progress novel cardiovascular technologies and medicines along the translational pathway towards human studies, phase II trials, patient benefit and/or commercialisation. Projects may span from pre-clinical development to early-phase clinical trials and must demonstrate a strong intellectual property position and a credible route to market. Grants are milestone-driven, can last up to three years, and are intended to deliver a significant scientific or value inflection point. Funding may be used flexibly for staff (excluding PhD studentships), consumables, equipment, consultancy and outsourced services.

Project funding for salaries (excluding PhD studentships), consumables, equipment, consultancy, outsourced contract research and limited project management support.

The principal investigator must be a researcher working in an established research institution in the UK. Individuals or teams from commercial organisations may participate as collaborators; applications must be completed in partnership with the institution's Technology Transfer Office.

Two-stage application completed in partnership with the institution's Technology Transfer Office via the BHF Grant Management System (applications assessed in a two-stage process).